L. Aaltonen
Sun 25 15:30
S8.1
Symposium 8: Endocrine tumours: new genes and association with syndromes
Pituitary adenoma predisposition caused by AIP germline mutations
Silvano Adami
Sun 25 19:10
Satellite Symposium: Progress in the management of postmenopausal osteoporosis
RANK Ligand inhibition: the clinical evidence
Bruno Allolio
Würzburg, Germany
Mon 26 18:45
Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
New approaches to the diagnosis of hyponatraemia
Würzburg, Germany
C.Y. Anderson
Sun 25 15:30
S7.1
Symposium 7: Approaches to preservation of gonadal function after cancer therapy
Ovarian transplantation
B. Asvold
Mon 26 11:35
S13.2
Symposium 13: The TSH Reference Range
Health outcomes related to TSH values within the reference range
K. Badenhoop
Tue 27 09:45
S19.3
Symposium 19: Fetal microchimerism as an explanation of disease
The role of microchimerism in autoimmune diseases
A. Bashamboo
Mon 26 08:45
S11.1
Symposium 11: Premature Ovarian Failure (POF)
A pivotal role for NR5A1 in human reproductive processes
D. Bassett
Sun 25 09:30
S3.3
Symposium 3: Bone Cell Biology
The role of the hypothalamic-pituitary-thyroid axis in bone
R. Batterham
Wed 28 08:00
S28.1
Symposium 28: Hypothalamic networks and energy homeostasis
PYY and the regulation of appetite control
A. Beckers
Sun 25 16:30
S8.3
Symposium 8: Endocrine tumours: new genes and association with syndromes
Update on familial pituitary tumours: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma
Paolo Beck-Peccoz
Mon 26 18:15
Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
Welcome and introduction
John Betteridge
Sat 24 13:50
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Thiazolidinediones in the treatment of type 2 diabetes mellitus in 2009
M. Bidlingmaier
Mon 26 16:30
S16.3
Symposium 16: Hot Topics in Pituitary Disease
Problems with GH and IGF-1 assays: progress?
John Bilezikian
Mon 26 18:15
Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
Welcome from the chair
Mon 26 18:50
Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
Non-traditional features of modern PHPT
W. Birchmeier
Mon 26 11:15
S15.1
Symposium 15: Wnt Signalling
Wnt/Beta-Catenin Controls Stem Cells in Regeneration and Tumor Formation
Jens Bollerslev
Mon 26 18:20
Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
PHPT: prevalence and clinical presentation today
A. Borini
Sun 25 16:30
S7.3
Symposium 7: Approaches to preservation of gonadal function after cancer therapy
Oocyte cryopreservation
L. Brunerova
Tue 27 08:50
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
Relationship between metabolic parameters and central dopaminergic activity in healthy men
G. Castoria
Tue 27 15:30
S25.1
Symposium 25: Non-classical responses to hormones
Rapid androgen action in epithelial and stromal cells.
A. Clement
Wed 28 09:00
S27.4
Symposium 27: Multifaceted aspects of neuroprotection
Oestrogen and corticotropin releasing hormone: Two hormones with different targets in neuroprotection
M. Coculescu
Tue 27 11:45
S20.2
Symposium 20: The endocrine incidentaloma
Pituitary incidentalomas
Anna Colao
Mon 26 18:45
Satellite Symposium: Clinical insights on pituitary tumours
Achieving optimal outcomes for the patient with Acromegaly
W. Colledge
Mon 26 15:30
S17.1
Symposium 17: Genetic basis of infertility: Clinical studies and animal models
Genetically modified mouse models for the analysis of reproductive disorders
G. Corona
Sun 25 09:30
S2.4
Symposium 2: Endocrine aspects of the metabolic syndrome
Testosterone treatment in the metabolic syndrome
Carolyn Deacon
Sat 24 16:20
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Cardiovascular effects of incretin-based therapies
Michaela Diamant
Sat 24 15:20
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Incretin system and type 2 diabetes mellitus: GLP-1 agonists
C. Dode
Mon 26 16:30
S17.3
Symposium 17: Genetic basis of infertility: Clinical studies and animal models
Genetics of Kallmann syndrome
Dr Daniel Drucker
Toronto, Canada
Tue 27 10:15
PL5
Plenary Lecture 5
Discovery and relevance of the Incretin System
Toronto, Canada
D. Dunger
Sun 25 08:50
S2.2
Symposium 2: Endocrine aspects of the metabolic syndrome
Combined GH and IGF-1 treatment
S. Eskes
Wed 28 08:30
S26.2
Symposium 26: Adverse effects of drugs on thyroid
Treatment of amiodarone-induced thyrotoxicosis type 2: a RCT
M. Fassnacht
Tue 27 16:00
S24.2
Symposium 24: Diagnosis and treatment of endocrine malignancies
Diagnosis and treatment of adrenocortical carcinomas
Richard Feelders
Mon 26 19:15
Satellite Symposium: Clinical insights on pituitary tumours
Strategies for improving outcomes for the patient with Cushings disease
U. Feldt-Rasmussen
Sun 25 18:45
Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
Can early levothyroxine treatment reduce the cardiovascular risk in subclinical hypothyroidism
S. Ferarri
Mon 26 09:15
S10.2
Symposium 10: Novel aspects in the treatment of bone disease
Preclinical and clinical effects of RANK ligand inhibition
E. Fliers
Sun 25 08:30
S2.1
Symposium 2: Endocrine aspects of the metabolic syndrome
Brain-adipose and brain-liver connections in the metabolic syndrome
E. Friesema
Mon 26 08:45
S12.1
Symposium 12: Thyroid hormone metabolism and action: new developments
Thyroid hormone transporters
V. Galton
Mon 26 09:05
S12.2
Symposium 12: Thyroid hormone metabolism and action: new developments
Life without T4 to T3 conversion
L.M. Garcia-Segura
Wed 28 08:20
S27.2
Symposium 27: Multifaceted aspects of neuroprotection
Relationship between oestrogen and IGF system in neuroprotection
Oksana Gavrilova
Sat 24 13:00
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Can diabetes be treated by targeting adipose tissue? Lessons from animal models
R. Granata
Sun 25 09:10
S2.3
Symposium 2: Endocrine aspects of the metabolic syndrome
Unacylated ghrelin: a metabolic hormone
M. Guldstrand
Tue 27 16:30
S23.3
Symposium 23: Obesity: clinical manifestations and therapeutic intervention
Hormonal changes after bariatric surgery
Martin Haluzik
Sat 24 13:25
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Endocrine function of adipose tissue from bench to bedside
M. Hewison
Mon 26 11:55
S14.3
Symposium 14: Novel actions of vitamin D
Vitamin D dependent anti-microbio pathways
O. Hiort
Sun 25 09:15
S1.4
Symposium 1: European Networks
The EuroDSD project and consortium
L. Hofbauer
Sat 24
Opening Ceremony: European Journal of Endocrinology Prize Lecture
Translating bone cell biology into clinical practice: target identified as RANK ligand
Lorenz Hofbauer
Sun 25 18:45
Satellite Symposium: Progress in the management of postmenopausal osteoporosis
RANK Ligand - from molecular discovery to a novel understanding of osteoporosis
W. Holzgreve
Tue 27 09:15
S19.2
Symposium 19: Fetal microchimerism as an explanation of disease
Molecular microchimerism detection - its importance for non-invasive prenatal diagnosis and preeclampsia
Philip Home
Sat 24 14:20
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Side effects of thiazolidinediones: how important they really are?
T. Horvath
Wed 28 09:00
S28.3
Symposium 28: Hypothalamic networks and energy homeostasis
Hypothalamic plasticity and the central control of energy balance
I. Huhtaniemi
Sun 25 11:15
S4.1
Symposium 4: The Ageing Male
Genetic aspects of aging in men
E. Husebye
Sun 25 09:30
S1.5
Symposium 1: European Networks
EurAdrenal
S. Incerpi
Tue 27 16:30
S25.4
Symposium 25: Non-classical responses to hormones
Extranuclear effects of thyroid hormones
K. Jazdzewsji
Tue 27 11:45
S22.2
Symposium 22: MicroRNAs in endocrinology
MicroRNAs in thyroid cancer
M. Kassem
Sun 25 08:30
S3.1
Symposium 3: Bone Cell Biology
Skeletal stem cells and mechanisms of bone formation
A.S. Kauffman
Sun 25 11:15
S6.1
Symposium 6: Neuroendocrine control of reproduction
Sexual differentiation of hypothalamic Kiss1 neurons
A. Kautzky-Willer
Tue 27 08:45
S18.1
Symposium 18: Diabetes in pregnancy
Progress towards new criteria for diagnosis and classification of glucose metabolism during pregnancy
P. Kovanen
Sun 25 16:00
S9.2
Symposium 9: The role of oxidative stress in the development of the metabolic syndrome
Macrophage dysfunction and insulin resistance
M. Kraenzlin
Mon 26 09:45
S10.3
Symposium 10: Novel aspects in the treatment of bone disease
Teriparatide and parathyroid hormone in the treatment of ostoporosis
M. Laudes
Tue 27 09:40
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
Adipose tissue development and human metabolic disease
H. Leeuwen
Mon 26 12:15
S14.4
Symposium 14: Novel actions of vitamin D
Vitamin D and differentiation of mesenchymal stem cells and osteoblasts
H. Leffers
Tue 27 11:15
S22.1
Symposium 22: MicroRNAs in endocrinology
MicroRNAs in biology
M.N. Lehman
Sun 25 11:35
S6.2
Symposium 6: Neuroendocrine control of reproduction
KNDy (kisspeptin/neurokinin B/dynorphin) cells of the arcuate nucleus: a central node in the control of GnRH secretion
J. Levine
Sun 25 11:55
S6.3
Symposium 6: Neuroendocrine control of reproduction
Consequences of Non-Classical ERα Signaling in Brain
K. Liu
Mon 26 09:05
S11.2
Symposium 11: Premature Ovarian Failure (POF)
Premature ovarian failure due to overactivation of primordial follicles in mice
M. Lopex
Wed 28 08:30
S28.2
Symposium 28: Hypothalamic networks and energy homeostasis
Brain lipogenesis and the control of food intake: the lipostatic hypothesis revisited
R. Lovell-Badge
Tue 27 17:30
PL6
Plenary Lecture 6
Sex and SOX
C. Mantzoros
Tue 27 15:30
S23.1
Symposium 23: Obesity: clinical manifestations and therapeutic intervention
Obesity: clinical manifestations and therapeutic. Does the choice of diet make any difference?
Claudio Marcocci
Mon 26 19:20
Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
Management of PHPT: What matters most?
Josef Marek
Sun 25 18:15
Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
Introduction
S. Mariotti
Mon 26 12:15
S13.4
Symposium 13: The TSH Reference Range
Solving the dilemma: what to do as a simple clinician
C. Mattieu
Mon 26 11:15
S14.1
Symposium 14: Novel actions of vitamin D
Vitamin D and Diabetes
Eugene McCloskey
Sun 25 18:20
Satellite Symposium: Progress in the management of postmenopausal osteoporosis
Burden of osteoporosis: why to treat and whom to treat?
R. Millar
Mon 26 10:15
PL3
Plenary Lecture 3
Novel regulator of Gonadotropin
J. Mittag
Mon 26 09:45
S12.4
Symposium 12: Thyroid hormone metabolism and action: new developments
Significance of thyroid receptor alpha in metabolism
A. Morris
Sun 25 19:05
Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
Cardiovascular benefit of metformine in adults with type 2 diabetes
A. Munoz
Mon 26 11:35
S14.2
Symposium 14: Novel actions of vitamin D
Vitamin D and wnt signalling in colon cancer
A. Nadal
Tue 27 15:50
S25.2
Symposium 25: Non-classical responses to hormones
Non-classical actions of oestrogens in pancreas
T. Nystrom
Tue 27 11:15
S21.1
Symposium 21: The cardiometabolic interface
Endothelial dysfunction in type 2 diabetes
K. O'Donoghue
Tue 27 08:45
S19.1
Symposium 19: Fetal microchimerism as an explanation of disease
Microchimerism: Introduction and animal models
S. O'Rahilly
Wed 28 12:30
PL8
Plenary Lecture 8
An update on the genetics of obesity
K. Pacak
Wed 28 09:30
PL7
Plenary Lecture 7
New trends in diagnosis and localisation of (neuro) Endocrine Tumours
A. Pereira
Mon 26 16:00
S16.2
Symposium 16: Hot Topics in Pituitary Disease
The safety of dopamine agonists - Clinical perspective
A. Peri
Wed 28 08:00
S27.1
Symposium 27: Multifaceted aspects of neuroprotection
Relationship between oestrogen and cholesterol in neuroprotection
L. Persani
Mon 26 09:45
S11.4
Symposium 11: Premature Ovarian Failure (POF)
Genetic defects in ovarian growth/differentiation factors
D. Picard
Tue 27 12:15
S22.3
Symposium 22: MicroRNAs in endocrinology
The role of microRNAs in hormone signaling
P-F. Plouin
Tue 27 15:30
S24.1
Symposium 24: Diagnosis and treatment of endocrine malignancies
Malignant pheochromocytomas or paragangliomas
J. Polosak
Tue 27 09:30
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
The GG genotype of the G-11391A ADIPOQ poylmorphism might be a risk factor for development of type 2 diabetes mellitus in women
F. Pralong
Sun 25 12:15
S6.4
Symposium 6: Neuroendocrine control of reproduction
Insulin regulation of reproductive brain: Rodent and human studies
I. Robinson
Sat 24
Opening Ceremony: Geoffrey Harris Prize Lecture
Transgenes and physiology in the Growth Hormone axis: a view from the portal
M. Roden
Sun 25 15:30
S9.1
Symposium 9: The role of oxidative stress in the development of the metabolic syndrome
Mitochondrial dysfunction and insulin resistance
P. Rodien
Wed 28 08:00
S26.1
Symposium 26: Adverse effects of drugs on thyroid
Tyrosine kinase inhibitors and thyroid
G. Russell
Mon 26 08:45
S10.1
Symposium 10: Novel aspects in the treatment of bone disease
Principles of bone biology (the major pathways, RANKL, SOST, Wnt etc)
L. Sacca
Sun 25 18:25
Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
Cardiovascular impact of GH therapy in adult Gh deficient patients
M. Santoro
Sun 25 11:45
S5.2
Symposium 5: Novel targets for thyroid cancer treatment
Molecular mechanisms in thyroid cancer
T. Scanlon
Mon 26 17:15
PL4
Plenary Lecture 4
Thyronamines: Beyond T4 and T3
G. Schernthaner
Tue 27 09:45
S18.3
Symposium 18: Diabetes in pregnancy
Gestational diabetes: High risk for future diabetes and cardiovascular disease
S. Schinner
Mon 26 11:45
S15.2
Symposium 15: Wnt Signalling
Wnt signaling and the metabolic syndrome
S. Schmid
Tue 27 08:45
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
Welcome & Introduction to YAR (DGE-ESE)
D. Schulte
Tue 27 10:10
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
Closing and invitation for the YAR meeting in 2010
M. Schumacher
Wed 28 08:40
S27.3
Symposium 27: Multifaceted aspects of neuroprotection
Progesterone and the nervous system
Dr Robert Semple
UK
Tue 27 09:00
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
Novel syndromes of abnormal insulin sensitivity - lessons for common disease
UK
J. Sethi
Mon 26 12:15
S15.3
Symposium 15: Wnt Signalling
Adipogenesis, diabetes and wnt signaling
Michael Sheppard
Mon 26 18:15
Satellite Symposium: Clinical insights on pituitary tumours
A review of current practice and outcomes from patients with pituitary tumors
W. Simonides
Mon 26 09:25
S12.3
Symposium 12: Thyroid hormone metabolism and action: new developments
Thyroid hormone signalling in the heart
N. Skakkebaek
Sun 25 17:15
PL2
Plenary Lecture 2
Testicular dysgenesis and endocrine disruptors
J. Smit
Sun 25 12:15
S5.3
Symposium 5: Novel targets for thyroid cancer treatment
Tyrosine kinase inhibitors in thyroid cancer
C. Spitzweg
Sun 25 11:15
S5.1
Symposium 5: Novel targets for thyroid cancer treatment
Sodium Iodide Symporter
B. Staels
Tue 27 11:45
S21.2
Symposium 21: The cardiometabolic interface
Role of PPAR signalling in diabetic dyslipidemia
C. Stratakis
Sun 25 16:00
S8.2
Symposium 8: Endocrine tumours: new genes and association with syndromes
New multiple endocrine neoplasias: endocrine tumours associated with gastrointestinal stromal tumours (GISTs)
B. Szende
Tue 27 16:30
S24.3
Symposium 24: Diagnosis and treatment of endocrine malignancies
Parathyroid carcinomas
A. Tabarin
Mon 26 15:30
S16.1
Symposium 16: Hot Topics in Pituitary Disease
Pros and Cons of large scale screening of Cushing's syndrome
A. Themmen
Mon 26 09:25
S11.3
Symposium 11: Premature Ovarian Failure (POF)
Ovarian AMH - Implications for the diagnosis of premature ovarian failure
T. Thomas
Sun 25 09:00
S3.2
Symposium 3: Bone Cell Biology
Cross talks between Leptin and the skeleton
W. Thomas
Tue 27 16:10
S25.3
Symposium 25: Non-classical responses to hormones
Protein kinase D as a modulator of aldosterone action in the kidney
Chris Thompson
Mon 26 18:20
Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
Mild and moderate hyponatraemia - is treatment necessary?
Y. Tomer
Wed 28 09:00
S26.3
Symposium 26: Adverse effects of drugs on thyroid
Interferons and thyroid
J. Tomlinson
Tue 27 16:00
S23.2
Symposium 23: Obesity: clinical manifestations and therapeutic intervention
Lifestyle intervention and pharmacologic approaches to weight loss
A.K. Topaloglu
Mon 26 16:00
S17.2
Symposium 17: Genetic basis of infertility: Clinical studies and animal models
Neurokinin B signalling in human puberty
J. Toppari
Sun 25 08:45
S1.2
Symposium 1: European Networks
NECTAR - Network for Environmental Chemical Toxicants Affecting Reproduction
T. Travison
Sun 25 12:15
S4.3
Symposium 4: The Ageing Male
The natural history of symptomatic androgen deficiency in men: Longitudinal results from the Massachussets Male Aging Study
S. Tsagarakis
Tue 27 12:15
S20.3
Symposium 20: The endocrine incidentaloma
Adrenal Incidentalomas
D. Vanderschueren
Sun 25 11:45
S4.2
Symposium 4: The Ageing Male
Osteoporosis in the aging male
B. Velkeniers
Mon 26 11:55
S13.3
Symposium 13: The TSH Reference Range
A critical synopsis of current meta-analyses in the field of subclinical thyroid disease
Joseph Verbalis
Georgetown University, USA
Mon 26 19:05
Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
Considering new treatments in the management of hyponatraemia: Case study highlights
Georgetown University, USA
P. Vitti
Tue 27 11:15
S20.1
Symposium 20: The endocrine incidentaloma
Thyroid incidentaloma. Endocrine incidentaloma
H. Vlassara
Sun 25 16:30
S9.3
Symposium 9: The role of oxidative stress in the development of the metabolic syndrome
Marked improvement of insulin resistance by reduced AGE intake; a non-pharmacologic, non-nutrient based intervention for type 2 diabetes
H. Voelzke
Mon 26 11:15
S13.1
Symposium 13: The TSH Reference Range
Determinants of the TSH reference range
M. Vrablik
Tue 27 12:15
S21.3
Symposium 21: The cardiometabolic interface
Mechanism and treatment of diabetic dyslipidemia
S. Webb
Sun 25 09:45
S1.6
Symposium 1: European Networks
The European Registry on Cushing’s Syndrome (ERCUSYN) Database: First year experience
W. Wiersinga
Sun 25 09:00
S1.3
Symposium 1: European Networks
EUGOGO
D. Williams
Sun 25 10:15
PL1
Plenary Lecture 1
Twenty years' experience with post-Chernobyl thyroid cancer
M. Wolff
Sun 25 16:00
S7.2
Symposium 7: Approaches to preservation of gonadal function after cancer therapy
ART/IVF and cryopreservation
C. Worda
Tue 27 09:15
S18.2
Symposium 18: Diabetes in pregnancy
New treatment modalities in diabetic pregnancy
F. Wu
Sun 25 08:30
S1.1
Symposium 1: European Networks
Endocrinology of the Ageing Male – The European Male Ageing Study (EMAS)
Hannele Yki-Jarvinen
Sat 24 15:50
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
DPP-4 agonists in the treatment of type 2 diabetes mellitus
Sun 25 07:00
Satellite Symposia: Controversial Issues in Acromegaly

Faculty presentations will be based on a pre-meeting e-poll

Sponsored by Pfizer
Room: Forum Hall
Chair: Ezio Ghigo (Italy)
Tue 27 11:15
OC5.1
Oral Communications 5: Reproduction & Thyroid
Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model
Tue 27 11:30
OC5.2
Oral Communications 5: Reproduction & Thyroid
The influence of cure of subclinical hyperthyroidism on diastolic diameters of heart chambers and cardiac index
Tue 27 11:45
OC5.3
Oral Communications 5: Reproduction & Thyroid
Socio-economic factors and mortality in Turner syndrome – a registry study
Tue 27 12:00
OC5.4
Oral Communications 5: Reproduction & Thyroid
One hormone, two functions - The chorionic gonadotropin in New World Monkeys
Tue 27 12:15
OC5.5
Oral Communications 5: Reproduction & Thyroid
Predictive factors of intermittent ovarian function in Patients with Premature Ovarian Failure
Tue 27 12:30
OC5.6
Oral Communications 5: Reproduction & Thyroid
Universal screening detects twice more thyroid disorders in early pregnancy than targeted high-risk case finding
Tue 27 15:30
OC6.1
Oral Communications 6: Bone
A proteomic approch to study parathyroid glands
Tue 27 15:45
OC6.2
Oral Communications 6: Bone
Association between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism
Tue 27 16:00
OC6.3
Oral Communications 6: Bone
Six novel mutations in 25-hydroxyvitamin D3 1alpha hydroxylase gene in patients with pseudovitamin D deficiency rickets.
Tue 27 16:15
OC6.4
Oral Communications 6: Bone
Age-dependent features of bone mineral density changes in male rats with hyperthyroidism
Tue 27 16:30
OC6.5
Oral Communications 6: Bone
The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma.
Tue 27 16:45
OC6.6
Oral Communications 6: Bone
Suppression of Circulating Fibroblast Growth Factor-23 by Cinacalcet in Patients with Primary Hyperparathyroidism

0 result(s) found.